1. Home
  2. YOUL vs FLNA Comparison

YOUL vs FLNA Comparison

Compare YOUL & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YOUL

Youlife Group Inc. American Depositary Shares

HOLD

Current Price

$0.45

Market Cap

73.0M

Sector

Real Estate

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$1.24

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YOUL
FLNA
Founded
2020
1998
Country
China
United States
Employees
424
20
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.0M
61.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YOUL
FLNA
Price
$0.45
$1.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.8M
359.0K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$1.16
52 Week High
$4.40
$2.03

Technical Indicators

Market Signals
Indicator
YOUL
FLNA
Relative Strength Index (RSI) 43.75 38.38
Support Level $0.38 $1.16
Resistance Level $1.06 $1.80
Average True Range (ATR) 0.18 0.09
MACD -0.00 -0.01
Stochastic Oscillator 16.91 11.63

Price Performance

Historical Comparison
YOUL
FLNA

About YOUL Youlife Group Inc. American Depositary Shares

Youlife Group Inc is a blue-collar lifetime service platform in China, dedicated to serving the needs throughout the entire life cycle of the blue-collar talent. It provides blue-collar lifetime services to students, blue-collar talent, and corporate customers. Its segments are the vocational education segment, which engages in the provision of vocational education entrusted management services, self-operated vocational school services, and Others; the HR recruitment segment engages in the provision of HR recruitment services regarding blue-collar talent to customers; the employee management segment engages in the provision of labor outsourcing services, labor dispatch services and others; and the market service segment engages in the provision of value-added services.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: